{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:55:20Z","timestamp":1778644520941,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82072897 and 82002773"],"award-info":[{"award-number":["No. 82072897 and 82002773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82072897 and 82002773"],"award-info":[{"award-number":["No. 82072897 and 82002773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82072897 and 82002773"],"award-info":[{"award-number":["No. 82072897 and 82002773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82072897 and 82002773"],"award-info":[{"award-number":["No. 82072897 and 82002773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04260-3","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:16:09Z","timestamp":1772630169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Omitting axillary lymph node dissection or not? A multicenter, retrospective study for breast cancer patients potentially eligible for abemaciclib since the SENOMAC trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Zihao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"3","key":"4260_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J Clin. 2024;74(3):229\u201363.","journal-title":"J Clin"},{"issue":"6","key":"4260_CR2","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians. 2022;72(6):524\u201341.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"19","key":"4260_CR3","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med. 2017;377(19):1836\u201346.","journal-title":"N Engl J Med"},{"issue":"2","key":"4260_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.annonc.2025.10.005","volume":"37","author":"S Johnston","year":"2025","unstructured":"Johnston S, Martin M, O\u2019Shaughnessy J, Hegg R, Tolaney SM, Guarneri V, et al. Overall survival with abemaciclib in early breast cancer. Ann Oncol. 2025;37(2):155\u201365.","journal-title":"Ann Oncol"},{"issue":"11","key":"4260_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.6004\/jnccn.2025.0053","volume":"23","author":"WJ Gradishar","year":"2025","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines\u00ae Insights: Breast Cancer, Version 5.2025. J Natl Compr Canc Netw. 2025;23(11):426\u201336.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"4260_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1200\/JCO.1999.17.1.143","volume":"17","author":"F Thomas","year":"1999","unstructured":"Thomas F, Hack LC, Joel Katz LS. Robson, and Paul Goss. Physical and Psychological Morbidity After Axillary Lymph Node Dissection for Breast Cancer. J Clin Oncol. 1999;17(1):143\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4260_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/sj.bjc.6601150","volume":"89","author":"F Peintinger","year":"2003","unstructured":"Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer. 2003;89(4):648\u201352.","journal-title":"Br J Cancer"},{"issue":"10","key":"4260_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA"},{"issue":"12","key":"4260_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol"},{"issue":"13","key":"4260_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","volume":"390","author":"J de Boniface","year":"2024","unstructured":"de Boniface J, Filtenborg Tvedskov T, Ryd\u00e9n L, Szulkin R, Reimer T, K\u00fchn T, et al. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases. N Engl J Med. 2024;390(13):1163\u201375.","journal-title":"N Engl J Med"},{"issue":"9","key":"4260_CR11","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Th\u00fcrlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24(9):2206\u201323.","journal-title":"Ann Oncol"},{"issue":"24","key":"4260_CR12","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1200\/JCO.20.03613","volume":"39","author":"SM Tolaney","year":"2021","unstructured":"Tolaney SM, Garrett-Mayer E, White J, Blinder VS, Foster JC, Amiri-Kordestani L, et al. Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0. J Clin Oncol. 2021;39(24):2720\u201331.","journal-title":"J Clin Oncol"},{"issue":"12","key":"4260_CR13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jamasurg.2024.3944","volume":"159","author":"I Skarping","year":"2024","unstructured":"Skarping I, Bendahl P-O, Szulkin R, Alkner S, Andersson Y, Bergkvist L, et al. Prediction of High Nodal Burden in Patients With Sentinel Node\u2013Positive Luminal ERBB2-Negative Breast Cancer. JAMA Surg. 2024;159(12):1393\u2013 403.","journal-title":"JAMA Surg"},{"issue":"5","key":"4260_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(5):561\u20134.","journal-title":"J Clin Oncol"},{"issue":"14","key":"4260_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1200\/JCO-25-00099","volume":"43","author":"KU Park","year":"2025","unstructured":"Park KU, Somerfield MR, Anne N, Brackstone M, Conlin AK, Couto HL, et al. Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2025;43(14):1720\u201341.","journal-title":"J Clin Oncol"},{"issue":"25","key":"4260_CR16","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","volume":"384","author":"ANJ Tutt","year":"2021","unstructured":"Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, et al. Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. N Engl J Med. 2021;384(25):2394\u2013405.","journal-title":"N Engl J Med"},{"issue":"10","key":"4260_CR17","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1245\/s10434-016-5330-0","volume":"23","author":"D McCartan","year":"2016","unstructured":"McCartan D, Stempel M, Eaton A, Morrow M, Pilewskie M. Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients. Ann Surg Oncol. 2016;23(10):3324\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"29","key":"4260_CR18","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1200\/JCO.22.00173","volume":"40","author":"EA Mittendorf","year":"2022","unstructured":"Mittendorf EA, King TA, Tolaney SM. Impact of RxPONDER and monarchE on the Surgical Management of the Axilla in Patients With Breast Cancer. J Clin Oncol. 2022;40(29):3361\u20134.","journal-title":"J Clin Oncol"},{"issue":"7","key":"4260_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41416-024-02580-3","volume":"130","author":"T Gaillard","year":"2024","unstructured":"Gaillard T, Piketty J, Feron J-G, Girard N, Pauly L, Gauroy E, et al. Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib. Br J Cancer. 2024;130(7):1141\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"4260_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10549-025-07642-5","volume":"212","author":"C Jankowski","year":"2025","unstructured":"Jankowski C, Houvenaeghel G, Renaudeau C, Leveque J, Marchal F, Benbara A, et al. How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial? Breast Cancer Res Treat. 2025;212(1):13\u201321.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"4260_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12282-025-01684-9","volume":"32","author":"K Kawashima","year":"2025","unstructured":"Kawashima K, Narui K, Nishikawa A, Sasamoto M, Oshi M, Adachi S, et al. The impact of axillary lymph-node dissection omission on adjuvant abemaciclib eligibility in HR-positive, HER2-negative breast cancer with positive sentinel lymph nodes. Breast Cancer. 2025;32(3):543\u201351.","journal-title":"Breast Cancer"},{"issue":"9","key":"4260_CR22","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S1470-2045(24)00350-4","volume":"25","author":"J de Boniface","year":"2024","unstructured":"de Boniface J, Appelgren M, Szulkin R, Alkner S, Andersson Y, Bergkvist L, et al. Completion axillary lymph node dissection for the identification of pN2\u20133 status as an indication for adjuvant CDK4\/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial. Lancet Oncol. 2024;25(9):1222\u201330.","journal-title":"Lancet Oncol"},{"issue":"13","key":"4260_CR23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1200\/JCO.2007.11.9479","volume":"26","author":"A Katz","year":"2008","unstructured":"Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, et al. Nomogram for the Prediction of Having Four or More Involved Nodes for Sentinel Lymph Node\u2013Positive Breast Cancer. J Clin Oncol. 2008;26(13):2093\u20138.","journal-title":"J Clin Oncol"},{"key":"4260_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.breast.2020.08.001","volume":"53","author":"Z Yang","year":"2020","unstructured":"Yang Z, Lan X, Huang Z, Yang Y, Tang Y, Jing H, et al. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes. Breast. 2020;53:143\u201351.","journal-title":"Breast"},{"issue":"12","key":"4260_CR25","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJMoa2305488","volume":"390","author":"D Slamon","year":"2024","unstructured":"Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, et al. Ribociclib plus Endocrine Therapy in Early Breast Cancer. N Engl J Med. 2024;390(12):1080\u201391.","journal-title":"N Engl J Med"},{"key":"4260_CR26","unstructured":"Adjuvant ribociclib (RIB). plus nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+\/HER2\u2009\u2013\u2009early breast cancer (EBC): NATALEE 5-year outcomes. 2025 ESMO LBA14. 2025."},{"issue":"18","key":"4260_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa2412225","volume":"393","author":"IH Kunkler","year":"2025","unstructured":"Kunkler IH, Russell NS, Anderson N, Sainsbury R, Dixon JM, Cameron D, et al. Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer. N Engl J Med. 2025;393(18):1771\u201383.","journal-title":"N Engl J Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04260-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:17:26Z","timestamp":1775819846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04260-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4260"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04260-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Review Boards of Ruijin Hospital (No. 2023126). All participants included in this study signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}